The FDA approved the first-ever medication for obstructive sleep apnea in December 2024, expanding a treatment landscape that has long centered on continuous positive airway pressure machines.
GOLETA, Calif.--(BUSINESS WIRE)-- Inogen, Inc. (INGN) (Nasdaq: INGN), a leading medical technology company specializing in innovative respiratory products for homecare use, today announced the launch ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results